More than 300 participants from all over the world
(more than 40 countries) attended the symposia
Event Programme
|
|
Moderated by M. van Daalen |
|
|
Prof. Dr. C. Rüegg (Director of PSI) |
Opening Remarks |
08.30 |
|
Prof. Dr. R. Schibli |
Chair |
08.45 |
|
Dr. N. van der Meulen |
TATTOOS – project plans at PSI |
08.50 (20 + 5 min questions) |
|
Prof. Michael Hofman (Peter MacCallum Cancer Centre, Melbourne, Australia) |
A new Era of Treating Prostate Cancer: Improving Outcomes with Theranostics |
09.15 (20 min + 5 min questions) |
|
Prof. Dr. Richard Baum (CURANOSTICUM Wiesbaden-Frankfurt, Germany) |
“From innovation to implementation: Advancing Radiomolecular Precision Oncology (RPO) by novel radiosiotopes for Theranostics of Personalized Cancer Care” |
09.40 (20 min + 5 min questions) |
|
|
Short break |
10.05 min |
|
PD Dr. C. Müller |
Chair |
10.15 |
|
Prof. Dr. George Thalmann (Inselspital,Bern, Bern, Switzerland) |
Theranostics in prostate cancer: the urologists view of unmet needs and hopes |
10.40 (20 min + 5 min questions) |
|
Prof. Dr. Damian Wild (University Hospital Basel, Basel Switzerland) |
Theranostics in Neuroendocrine Neoplasia (NEN) – new Treatment Options |
11.05 (20 min + 5 min questions) |
|
Dr. Ulli Köster (Institut Laue-Langevin, Grenoble, France) |
Production of emerging radionuclides |
11.30 (20 + 5 min question)s |
|
|
Short break |
11.55 |
|
Prof. Dr. R. Schibli |
Round Table Discussion (Q&A Session) with: - Directorate, invited Speakers, representative of LRC, representative of CRS, invited Medical Doctors, representatives of industry |
12.05 (45 min) |
|
|
Break |
|
|
|
Closing remarks |
13.00 |
